Defunct Company
Total Trials
15
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,728
NCT01821677
A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 26, 2013
Completion: Jan 23, 2015
NCT01839331
An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
Start: Mar 29, 2013
Completion: Oct 31, 2013
NCT02024529
A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee
Phase: Phase 3
Start: Jan 31, 2014
Completion: Jul 31, 2014
NCT02184156
A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain
Phase: Phase 1/2
Start: Jun 30, 2014
Completion: Oct 31, 2015
NCT02242435
A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis
Start: Sep 30, 2014
Completion: May 31, 2015
NCT02556710
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
Start: Sep 30, 2015
Completion: Jun 30, 2016
NCT02762760
AP-011 Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ for Arthritis of the Basal Thumb Joint
Phase: Phase 1
Start: May 31, 2016
Completion: Nov 30, 2016
NCT03182686
AP-003-C Study to Confirm the Efficacy of Ampion™ in Adults With Pain Due to Severe Osteoarthritis of the Knee
Start: Jun 19, 2017
Completion: Dec 7, 2017
NCT03349645
Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee
Start: Dec 8, 2017
Completion: Oct 4, 2018
NCT03988023
Study of Ampion for the Treatment of Pain and Function in Patients With Severe Osteoarthritis of the Knee.
Start: Jun 24, 2019
Completion: Jul 13, 2021
NCT04456452
Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation
Start: Jul 27, 2020
Completion: Nov 30, 2020
NCT04606784
Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress
Start: Oct 28, 2020
Completion: Jun 15, 2021
NCT04868890
A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19
Start: Jun 22, 2021
Completion: Apr 13, 2022
NCT04839965
Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen
Start: Jul 5, 2021
Completion: Apr 4, 2022
NCT04880161
A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)
Start: Jul 26, 2021
Completion: Feb 21, 2022